CA2015315A1 - Improved method of blood component decontamination by glucose addition and post-decontamination gassing - Google Patents
Improved method of blood component decontamination by glucose addition and post-decontamination gassingInfo
- Publication number
- CA2015315A1 CA2015315A1 CA002015315A CA2015315A CA2015315A1 CA 2015315 A1 CA2015315 A1 CA 2015315A1 CA 002015315 A CA002015315 A CA 002015315A CA 2015315 A CA2015315 A CA 2015315A CA 2015315 A1 CA2015315 A1 CA 2015315A1
- Authority
- CA
- Canada
- Prior art keywords
- decontamination
- gassing
- post
- improved method
- blood component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000005202 decontamination Methods 0.000 title 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title 1
- 239000012503 blood component Substances 0.000 title 1
- 230000003588 decontaminative effect Effects 0.000 title 1
- 239000008103 glucose Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 2
- 102000040430 polynucleotide Human genes 0.000 abstract 2
- 108091033319 polynucleotide Proteins 0.000 abstract 2
- 239000002157 polynucleotide Substances 0.000 abstract 2
- 230000001766 physiological effect Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical class C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 abstract 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Abstract
Biological compositions are freed of functional polynucleotides by treatment of the biological composition with psoralen derivatives under irradiation conditions in which the proteins retain their original physiological activities and any polynucleotide present is rendered inactive.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/350,335 US5176921A (en) | 1983-05-02 | 1989-05-11 | Method of blood component decontamination by glucose addition |
US07/350,335 | 1989-05-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2015315A1 true CA2015315A1 (en) | 1990-11-11 |
CA2015315C CA2015315C (en) | 2001-03-06 |
Family
ID=23376261
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2015315 Expired - Lifetime CA2015315C (en) | 1989-05-11 | 1990-04-24 | Improved method of blood component decontamination by glucose addition and post-decontamination gassing |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2015315C (en) |
-
1990
- 1990-04-24 CA CA 2015315 patent/CA2015315C/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA2015315C (en) | 2001-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU563557B2 (en) | Photochemical decontamination treatment of whole blood or blood components | |
CA2019580A1 (en) | Novel methods of treatment using ranolazine and related piperazine derivatives | |
EP0205579A4 (en) | Methods and compositions useful in the diagnosis and treatment of autoimmune diseases. | |
NO175616C (en) | Mix for stimulating hair growth | |
ES8600613A1 (en) | Body implants of extracellular matrix and means and methods of making and using such implants. | |
AU7818487A (en) | Intermittent aeration type biological treatment process and system therefor | |
CA2169173A1 (en) | Methods for stimulating erythropoiesis using thrombopoietin | |
EP0506893A4 (en) | Diagnosis and treatment of diseases | |
HU902004D0 (en) | New trombolitic preparations | |
AU2807689A (en) | Method for the treatment of body tissues and the administration of drugs thereto | |
AU3861989A (en) | Method for the treatment and the diagnosis of coronary heart disease | |
AU5413490A (en) | Photochemical treatment of blood vessels | |
CA2015315A1 (en) | Improved method of blood component decontamination by glucose addition and post-decontamination gassing | |
DE69014501D1 (en) | Process for the treatment of titanium alloy and piece made therewith. | |
NZ220495A (en) | A2a cyclopeptan-2-ones carrier containing methotrexate compositions | |
EP0267684A3 (en) | Human leukocyte interferon composition and skin treatment | |
EP0436717A4 (en) | Method of treatment with medical agents | |
EP0200527A3 (en) | Norfloxacin salt | |
Begum et al. | The pH dependent inhibitory effect of dieldrin on succinate dehydrogenase activity in fish Tilapia mossambica. | |
SU645647A1 (en) | Method of lobe-wise cutout of liver from blood circulation | |
DE68902569D1 (en) | METHODS AND PREPARATIONS FOR THE TREATMENT OF NIDDM. | |
Kozlovskaya et al. | Acetyl cholinesterase activity in the brain and collagen content in the vertebra of goldfish exposed to chlorofos. | |
AU6997287A (en) | The application of tissue plasminogen activator and oxypurinol in dissolving blood clots and in preventing damage to ischaemic tissue during reperfusion | |
OA08911A (en) | Diagnosis and treatment of double-stranded RNA deficiency states. | |
IL90867A0 (en) | Method of non-invasive determination of glucose in the blood |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |